• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Vbi Vaccines Inc CS (NQ: VBIV )

    0.0653 UNCHANGED
    Last Price Updated: 4:00 PM EDT, Aug 7, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Vbi Vaccines Inc CS

    < Previous 1 2 3 4 5 6 7 Next >
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Pre-market stock movers are a hot topic on Wednesday and we have all of the latest news traders need to know about them this morning! 
    Via InvestorPlace
    Why Fortinet Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Dow Jumps Over 300 Points; US Trade Gap Narrows In June
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Is VBI Vaccines (VBIV) Stock Up 62% Today?
    VBI Vaccines stock is up on Tuesday as shares of VBIV continue to be volatile after the company filed for bankruptcy last week. 
    Via InvestorPlace
    Topics Bankruptcy
    Exposures Financial Legal
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    We have all of the biggest pre-market stock movers that traders are going to want to read about on Tuesday! 
    Via InvestorPlace
    S&P 500 Down Over 100 Points; Actinium Pharmaceuticals Shares Plunge
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Dow Tumbles 950 Points; ISM Services PMI Surges In July
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Nasdaq Tumbles 3%; Tyson Foods Earnings Top Views
    Via Benzinga
    VBI Vaccines Provides an Update on its Restructuring Proceedings
    From VBI Vaccines Inc.
    Via Business Wire
    Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    VBI Vaccines Initiates Restructuring Proceedings Under CCAA to Implement a Review of its Strategic Alternatives
    From VBI Vaccines Inc.
    Via Business Wire
    VBI Vaccines Announces Results of Annual General Meeting
    From VBI Vaccines Inc.
    Via Business Wire
    VBI Vaccines Announces New Tumor Response Data from Ongoing Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma Patients
    From VBI Vaccines Inc.
    Via Business Wire
    VBI Vaccines Announces Poster Presentation at 2024 ASCO Annual Meeting Highlighting New Interim Phase 2b Data from VBI-1901 in Recurrent Glioblastoma Patients
    From VBI Vaccines Inc.
    Via Business Wire
    VBIV Stock Earnings: VBI Vaccines Misses EPS, Misses Revenue for Q1 2024
    VBIV stock results show that VBI Vaccines missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    VBI Vaccines Reports First Quarter 2024 Financial Results
    From VBI Vaccines Inc.
    Via Business Wire
    VBIV Stock Earnings: VBI Vaccines Beats EPS, Misses Revenue for Q4 2023
    VBIV stock results show that VBI Vaccines beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023. 
    Via InvestorPlace
    VBI Vaccines Reports Full Year 2023 Financial Results
    From VBI Vaccines Inc.
    Via Business Wire
    VBI Vaccines Announces Closing of $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    From VBI Vaccines Inc.
    Via Business Wire
    Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results. 
    Via Benzinga
    VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    From VBI Vaccines Inc.
    Via Business Wire
    Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
    Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results. 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    It's time to dive into all of the biggest pre-market stock movers that traders will want to keep an eye on Friday morning! 
    Via InvestorPlace
    VBI Vaccines Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma
    From VBI Vaccines Inc.
    Via Business Wire
    VBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine Platform
    From VBI Vaccines Inc.
    Via Business Wire
    Why Robinhood Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
    Shares of Robinhood Markets, Inc. (NASDAQ: HOOD) shares rose sharply in today’s pre-market trading after the company reported better-than-expected fourth- 
    Via Benzinga
    Why Sony Shares Are Trading Lower By Around 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Shares of Sony Group Corporation (NYSE: SONY) fell during Wednesday’s session after the company reported third-quarter financial results and revised guidance above estimates and shared plans to list... 
    Via Benzinga
    VBI Announces Agreement to Sell Manufacturing Capabilities, Certain Related Assets, and Enter Into New License Agreement with Brii Biosciences
    From VBI Vaccines Inc.
    Via Business Wire
    Why Faraday Future Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
    Shares of Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) surged in pre-market trading after the company announced its foray into the Middle Ea 
    Via Benzinga
    VBI Vaccines Presents Additional Biomarker Data from Phase 1/2a Study of VBI-1901 in Recurrent GBM at the 2023 Society for Neuro-Oncology (SNO) Annual Meeting
    From VBI Vaccines Inc.
    Via Business Wire
    < Previous 1 2 3 4 5 6 7 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.